Методы эндоваскулярного лечения при нестабильной стенокардии
Диссертация
Исследования. Статистические исследования свидетельствуют о том, что более 50% населения в возрасте свыше 65 лет страдают сердечно-сосудистыми заболеваниями. Только в США ежегодно 56 млн. человек диагностируют ишемическую болезнь сердца (ИБС), при этом почти 1 500 000 американцев переносят инфаркт миокарда (ИМ), а около 500 000 из них умирают. По данным Braunwald Е. с соавторами в США… Читать ещё >
Список литературы
- Аверков О.В. Клопидогрель: новые стандарты антитромбоцитарной терапии при внутри коронарных вмешательствах и возможные перспективы использования / О. В. Аверков // Фарматека. — 2003. — № 3. С. 36−43.
- Алекян Б.Г., Стаферов А. В. Коронарное стентирование // Интервенционные методы лечения ишемической болезни сердца / Под ред. Л. А. Бокерия, Б. Г. Алекяна, А. Коломбо, Ю. И. Бузиашвили. М.: Изд-во НЦССХ, 2002. Глава 11. — С. 226−261.
- Бабунашвили A.M. Коронарная ангиопластика / A.M. Бабунашвили, И. Х. Рабкин, В. А. Иванов. М.: Изд-во ABC, 1996. — 351 с.
- Бабунашвили A.M. Медикаментозное обеспечение стентирования / A.M. Бабунашвили, В. А. Иванов, С. А. Бирюков // Эндопротезирование (стентирование) венечных артерий сердца. М., 2001. — С. 415−431.
- Бабунашвили A.M. Методика выполнения коронарного стентирования / A.M. Бабунашвили // Эндопротезирование (стентирование) венечных артерий сердца. -М., 2000. С. 324−409.
- Бокерия Л.А. Интервенционные методы лечения ишемической болезни сердца / Л. А. Бокерия, Б. Г. Алекян, А. Коломбо, Ю. И. Бузиашвили -М.: Изд-во НЦССХ, 2002. С. 20.
- Бокерия Л.А., Гудкова Р. Г. Здоровье населения Российской Федерации и хирургическое лечение болезней сердца и сосудов в 2005 году — М.: Изд-во НЦССХ, 2003. С. 1−5.
- Бокерия JI.A. Сердечно-сосудистая хирургия 2003 / Л. А. Бокерия, Р. Г. Гудкова — Секц. по сердеч.-сосудистой хирургии Учен, совета М-ва здравоохранения и соц. Развития Рос. Федерации. — М.: Изд-во НЦССХ, 2004.- 108 с.
- Бокерия Л.А. Острый коронарный синдром. Возможности диагностики и лечения / Л. А. Бокерия, Ю. И. Бузиашвили, B.C. Работников, Б. Г. Алекян М.: Изд-во НЦССХ, 2004. — С. 78−99.
- Бокерия Л.А. Рентгенэндоваскулярная хирургия ишемической болезни сердца. 2008 / Л. А. Бокерия, Б. Г. Алекян — Руководство по рентгенэндоваскулярной хирургии сердца и сосудов — М.: Изд-во НЦССХ, 2008. Т. З — 646 с.
- Ганюков В.И. Антитромботическая сопутствующая терапия при 4KB / В. И. Ганюков, А. В. Протопопов // Чрескожные коронарные вмешательства при остром коронарном синдроме. — Новосибирск, 2005.-С. 62−81.
- И.Гланц С. Медико-биологическая статистика: пер. с англ. / С. Гланц — Ред.: Н. Е. Бузикашвили, Д. В. Самойлова. М.: Практика, 1999. -459 с.
- Гуревич B.C. Современные представления о патогенезе атероклероза // Болезни сердца и сосудов. 2006. — № 1 (4) — С. 4−10.
- Диагностика и лечение нестабильной стенокардии и инфаркта миокарда без элевации сегмента ST: рекомендации / Амер. ассоц. сердца и Амер. кардиол. колледж. Б.м., б.и., 2002. — 203 с.
- Иоселиани Д.Г., " Мовелидзе Т.А. Нестабильная стенокардия: консервативное или хирургическое лечение? Тбилиси: Ганатлеба, 1992.- 190 с.
- Кардиология в таблицах и схемах: пер. с англ. / Под ред. М. Фриде, С. Грайс. М.: Практика, 1996. — 733 с. — (Зарубежное практическое руководство по медицине — № 2).
- Никитин Ю.П. Новые фундаментальные и прикладные основы атерогенеза//Бюл. СО РАМН. 2006.-№ 2. — С. 6−14.
- Оганов Р.Г., Фомина И. Г., Аронов Д. М. и др. Кардиология: руководство для врачей. — М.: Медицина, 2004. 847 с.
- Пальцева Е.М. Уязвимая атеросклеротическая бляшка: Факторы, обуславливающие ее нестабильность // Молекулярная медицина. -2005. -№ 1.-С. 17−22.
- Рагино Ю.И. Активность воспалительно-деструктивных изменений в процессе формирования нестабильной атеросклеротической бляшки / Ю. И. Рагино, A.M. Чернявский, Полонская Я. В. и др. // Кардиоваск. терапия и профилактика. 2007. — № 9. С. 62−67.
- Рагино Ю.И. Факторы и механизмы нестабильности атеросклеротической бляшки / Ю. И. Рагино, A.M. Чернявский // Новосибирск: Изд-во Наука, 2008. 88 с.
- Розенберг В. Д. Коронарографические и патоморфологические особенности нестабильных бляшек при острых коронарных синдромах /В.Д. Розенберг, JI.M. Непомнящих // Бюл. экспер. биол. 2007. — № 144 (8). С. 229−236.
- Севергина JI.O. Морфогенез нестабильной атеросклеротической бляшки и ее роль в развитии острого коронарного синдрома // Арх. пат. 2005. -№ 3. С. 51−54.
- Соколов Ю.Н. Инвазивная кардиология и коронарная болезнь / Ю. Н. Соколов. Киев: Морион, 2002 — 359 с.
- Шлычкова Т.П. Патоморфологические особенности атеросклеротических бляшек при остром коронарном синдроме Шлычкова Т.П., Жданов B.C., Карпов Ю. А. // Арх. патол. 2005. -№ 3. — С. 24−28.
- Шлычкова Т.П. Основные типы нестабильных атеросклеротических бляшек и их распространенность в коронарных артериях при остром инфаркте миокарда Шлычкова Т.П., Черпаченко Н. М, Чумаченко П. В. // Кардиология. 2003. — № 12. — С. 42−46.
- A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet receptor inhibition in ischemic syndrome management in patient / PRISM study investigators // New England J. of Medicine. 1998. -Vol. 338.-P. 1498−1505.
- A randomized, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of IschaemicEvents / CAPRIE Steering Committee // Lancet. 1996. -Vol. 348.-P. 1329−1339.
- Alfonso F. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions / F. Alfonso et al. // J. of Amer. College of Cardiology. 1997. — Vol. 29. — P. 725−733.
- Ambrose J.A. Angiographic morphology and the pathogenesis of unstable angina pectoris / J.A. Ambrose et al. // J. of Amer. College of Cardiology. 1985. -Vol. 5. -P. 609−616.
- Amplatz K. Mechanics of selective coronary artery catheterization via femoral approach / Amplatz K. et al. // Radiology. 1967. — Vol. 89. — P. 1040.
- Antman E.M. Enoxaparin prevents death and cardiac ischemic events in unstable angina and non-Q wave myocardial infarction: result of the TIMI IIB trial / E.M. Antman et al. // Circulation. 1999. — Vol. 100. — P. 15 931 601.
- Armstrong P.W. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia- the GUSTO-IIb investigators / P.W. Armstrong // Circulation. 1998. — Vol. 98. — P. 18 601 868.
- Bailey S. Incidence and clinical impact of dissections after PTCA and stent placement: results from the randomized stent restenosis study / S. Bailey et al. // TCT Meeting (Washington, February, 1995). Washington, 2005. -P. .
- Balsano F. for Studio della Ticlopidina nelF Angina Instabile Group. Antiplatelet treatment with ticlopidin in unstable angina: a controlled multicenter clinical trial / F. Balsano et al. // Circulation. 1990. — Vol. 82. -P. 17−26.
- Barasch E. Effects of balloon material, balloon length, and inflation sequence on straightening forces in an in vitro model: PTCA in angulated segments / E. Barasch et al. // Catheter a. Cardiovascular Diagnosis. -1996.-Vol. 39.-P. 207−212.
- Bell M. Angiographic demonstration of spontaneous diffuse three vessels coronary artery spasm / M. Bell et al. // J. of Amer. College of Cardiology. 1989. — Vol. 14. — P. 523−527.
- Bellavance A. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events / A. Bellavance // Stroke. 1993. -Vol. 24. -P. 1452−1457.
- Bengston J. Interventions in unstable angina / J. Bengston, J. Wilson // Interventional cardiovascular medicine — principals and practice. — London, 1996.-P. .
- Bennett C.L. Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases / C.L. Bennett et al. // Annals of Internal Medicine. 1998. — Vol. 128. — P. 541−544.
- Bennett C.L. Thrombotic thrombocytopenic purpura associated with clopidogrel / C.L. Bennett et al. // New England J. of Medicine. 2000. -Vol. 342.-P. 1173−1177.
- Bentivoglio L.C. Short and long-term outcome of PTCA in unstable angina versus stable angina pectoris / L.C. Bentivoglio et al. // Catheter a. Cardiovascular Diagnosis. 1991. — Vol. 23. — P. 227.
- Berger P.B. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement / P.B. Berger et al. // Circulation. 1999. — Vol. 99. — P. 248−253.
- Boden W.E. Coronary angiographic findings after non-Q wave myocardial infarction: an analysis from the VANQWISH trial / W.E. Boden et al. // Europ. Heart J.-1997.-Vol. 18.-P. 123.
- Boden W.E. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy / W.E. Boden et al. // New England J. of Medicine. -1998. Vol. 338. — P. 1785−1792.
- Boneu B. Low-molecular-weight heparin therapy: is monitoring needed? / B. Boneu // Thrombosis a. Haemostasis. 1994. — Vol. 72. — P. 330−334.
- Braunwald E. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction / E. Braunwald // J. of Amer. College of Cardiology. 2002. -Vol.40. -P.1366.
- Braunwald E. Diagnosis and management unstable angina. Agency for health Care Policy and Research. / E. Braunwald et al. // Circulation. -1994.-Vol. 90, № 1.-P. 613−622.
- Braunwald E. Heart disease. A textbook of cardiovascular medicine. 5th ed. / E. Braunwald et al.- Ed. E. Braunwald Philadelphia: WB Saunders Co., 2001.-789 p.
- Braunwald E: Unstable angina: a classification / E. Braunwald // Circulation.- 1989.-Vol. 80.-P. 410.
- Budaj A. Effect of Clopidogrel in additional to aspirin in patients with acute coronary syndromes without ST-segment elevation / A. Budaj et al. // New England J. of Medicine.- 2001. -Vol. 345.-P. 494−502.
- Bugiardini R. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome / R. Bugiardini et al. // Amer. J. of Cardiology. 1991. — Vol. 67. — P. 460−464.
- Cadroy Y. Early potent antithrobmotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans / Y. Cadroy et al. // Circulation. 2000. — Vol. 101. — P. 28 232 828.
- Caims J.A. Aspirin, sulfinpyrazone, or both in unstable angina. Result of a Canadian multicenter trial / J.A. Cairns et al. // New England J. of Medicine. 1985.-Vol. 313.-P. 1369−1375.
- Cairns J.A. Unstable angina pectoris / J.A. Cairns, I.G. Fantus, G.A. Klassen // Amer. Heart J. 1976. — Vol. 92. — P. 373−386.
- Calvin J.E. Risk stratification in unstable angina: prospective validation of the Braunwald classification / J.E. Calvin et al. // JAMA. 1995. — Vol. 273.-P. 136.
- Campeau L. Grading of angina pectoris / L. Campeau // Circulation. 1976.- Vol. 54. P. 522−523.
- Chauhan A. Multiple coronary stenting in unstable angina: Early and late clinical outcomes / A. Chauhan et al. // Catheter a. Cardiovascular Diagnosis. 1998. — Vol. 43. — P. 11−16.
- Clarkson P.B. Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris / P.B. Clarkson et al. // Heart. -1990.-Vol. 81. -P. 393−397.
- Cohen M. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease / M. Cohen et al.. //New England J. of Medicine. 1997. — Vol. 337. — P. 447−452.
- Cohen M. Combination antithrombotic therapy in unstable rest angina and non-Q wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial / M. Cohen et al. // Circulation. 1994. — Vol. 89. -P. 81−88.
- Cohen M. Insights into the pathogenic mechanisms of unstable angina / M. Cohen, V. Fuster // Circulation. 1990. — Vol. 82. — P. 734−741.
- Collaborative overview of randomized trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by plonged antiplatelet therapy in various categories of patients // Brit. Med. J. 1994. -Vol. 308.-P. 81−106.
- Collet J.P. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris / J.P. et al. //Circulation.-2001.-Vol. 103.-P. 658−663.
- Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction /
- TIMI Study Group // New England J. of Medicine. 1989. — Vol. 320. — P. 618.
- Conti C. The role of coronary artery spasm in patients with angina pectoris / C. Conti // Coronary artery spasm.- S.I., 1986. Ch. 11. — P. 147−155.
- Conti C.R. Unstable angina pectoris: morbidity in 57 consecutive patients evaluated angiographically / C.R. Conti // Amer. J. of Cardiology. 1973. -Vol. 32, № 6.-P. 745−750.
- Cowley M.J. Acute coronary events associated with percutaneous transluminal coronary angioplasty / M.J. Cowley et al. // Amer. J. of Cardiology. 1984. — Vol. 53. -P. 12C-16C.
- Currier J.W. Pathophysiology of restenosis: clinical implications / J.W. Currier, C. Haudenschild, D.P. Faxon // Strategies in primary and secondary prevention of coronary artery disease. Berlin, 1992. — P. 181−192.
- De Benedictis M. Coronary stenting in unstable angina: angiographic and clinical implications / G. de Benedictis et al. // Ital. Cardiology. 1998. -Vol. 28.-P. 1099−1105.
- De Feyter P. Percutaneous transluminal coronary angioplasty for unstable angina / P. de Feyter, P. Serruys // Textbook of Interventional Cardiology. -New York, 1994.-P. 15−110.
- De Feyter P.J. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, management, and follow-up / P.J. de Feyter et al. // Circulation. 1991.-Vol. 83.-P. 927−936.
- De Feyter P.J. Coronary angioplasty for early postinfarction unstable angina / P.J. de Feyter et al. // Circulation. 1986. — Vol. 54. — P. 460.
- De Feyter P.J. PTCA early after the diagnosis of unstable angina / P.J. de Feyter et al. // Amer. Heart J. 1987. — Vol. 48. — P. 114.
- De Winter R.J. Early invasive versus selectively invasive management for acute coronary syndromes. ICTUS trial / R.J. de Winter // New England J. of Medicine.-2005.-Vol. 353.-P. 1095−1104.
- DeSanetis R.W. Guidelines for Coronary Angiography / R.W. DeSanetis et al. // J. of Amer. College of Cardiology. 1987. — Vol. 10. — P. 935−950.
- Detailed diagnoses and procedures: National Hospital Discharge Survey, 1996 / Nat. for Health Statistics. Hyattsville: Nat. Center for Health Statistics- 1998.- 13 p.
- Detre K. The coinvestigation of the National heart, lung and blood institute’s PTCA registry: percutaneous transluminal coronary angioplasty in 19 851 986 and 1977−1981 / K. Detre et al. // New England J. of Medicine. -1988. Vol. 318. — P. 214−223.
- Eagle K.A. Guidelines for coronary artery bypass graft surgery / K.A. Eagle et al. // J. of Amer. College of Cardiology. 1999. — Vol. 34. — P. 1262' 1347.
- Effects of platelet GP Ilb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty / The RESTORE investigators // Circulation. 1997.-Vol. 96.- 1445−1453.
- Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction / The TIMI IIIB investigators // Circulation. 1994. — Vol. 89. -P. 1545−1556.
- Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomized trial in acute myocardial infarction. // Lancet. 2001. — Vol. 358. — P. 605−613.
- Ellis S.G. Elective coronary angioplasty: technique and complications // Textbook of interventional cardiology. Philadelphia, 1999. — P. 147−162.
- Falk E. Coronary plaque disruption / E. Falk et al. // Circulation. 1995. -Vol. 92.-P. 657−671.
- Ferguson J.J. Adjunctive pharmacotherapy / J.J. Ferguson, M.S. Freed, R.D. Safian // The manual of interventional cardiology. Royal Oak, 2002. — P. 763−812.
- Ferguson J.J. The effect of body weight and body surface area correction of the distribution of the ACT response to bolus doses of heparin for PTCA / J.J. Ferguson et al. // J. of Invasive Cardiology. 1998. — Vol. 10. — P. 318−322.
- Ferguson J.J. The relationship between procedural activated clotting time and in-hospital post-PTCA outcome / Ferguson J.J. et al. // J. of Amer. College of Cardiology. 1994. — Vol. 23. — P. 1061.
- Fischman D.L. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease / D.L. Fischman et al. // New England J. of Medicine. 1994. — Vol. 331. — P. 496−501.
- Fowler N.O. Preinfarction angina. A need for an objective definition and for a controlled clinical trial of its management / N.O. Fowler // Circulation. 1971.-Vol. 44, № 5.-P. 755−758.
- Fox K.A. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial / K.A. Fox et al. // Lancet. 2002. -Vol. 360.-P. 743−751.
- Fox K.A. The ENACT study: a pan-European survey of acute coronary syndromes. European network for acute coronary treatment / K.A. Fox et al. // Europ. Heart J. 2000. — Vol. 21. — P. 1440−1449.
- Gabriel S.E. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis / S.E. Gabriel, L. Jaakkimainen, C. Bombardier // Annals of Internal Medicine. 1991. -Vol. 115.-P. 787−796.
- Gazes P.C. Preinfarction (unstable) angina a prospective study. Ten years follow-up / P.C. Gazes et al. // Circulation. — 1973. — Vol. 48. — P. 331.
- Gerstenblith G. Nifedipine in unstable angina: a double blind randomized trial / G. Gerstenblith et al. // New England J. of Medicine. -1982.-Vol. 306.-P. 885.
- Gibbons R.J. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina / R.J. Gibbons et al. // J. of Amer. College of Cardiology. 1999. — Vol. 33. — P. 2092−2197.
- Gibbons R.J. Guidelines for exercise testing / R.J. Gibbons et al. // J. of Amer. College of Cardiology. 1997. — Vol. 30. — P. 260−315.
- Gottlied S.O. Initial and late result of coronary angioplasty for early postinfarction unstable angina / S.O. Gottlied et al. // Catheter a. Cardiovascular Diagnosis. 1987. — Vol. 13. — P. 93.
- Granger C.B. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: result from the GUSTO-I trial / С. B. Granger et al. // Circulation. 1996. — Vol. 93. — P. 870−878.
- Granger C.B. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes / C.B. Granger et al. // Circulation. 1995. — Vol. 91. — P. 1929−1935.
- Gray W.A. The effects of balloon length and angle severity on the straightening force developed by polyethylene terephthalate (PET) angioplasty balloons / W.A. Gray, M.B. Ghazzal, H.L. White // Circulation. 1994.-Vol. 90.-P. 1−587.
- Grayburn P.A. In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: evidence for inadequate heparinization / P.A. Grayburn et al. // Catheter a. Cardiovascular Diagnosis. 1991. -Vol. 23.-P. 141−143.
- Gregorini L. Ticlopidine and aspirin pretreatment reduce coagulation and platelet activation during coronary dilatation procedures / L. Gregorini et al. // J. of Amer. College of Cardiology. 1997. — Vol. 29. — P. 13−20.
- Gruentzig A. Transluminal dilation of coronary artery stenosis / A. Gruentzig // Lancet. 1978. — Vol.1. — P. 263.
- Hasdai D.S. A prospective survey of the characteristics, treatments and oycomes of patients with acute coronary syndromes in Europe and the Mediterranean basin / D.S. Hasdai et al. // Europ. Heart J. 2002. — Vol. 23.-P. 1190−1201.
- Hass W.K. A randomized trial comparing ticlopidin hydrochloride with aspirin for the prevention of stroke in high-risk patients / W.K. Hass et al. //New England J. of Medicine. 1989. — Vol. 321. — P. 501−507.
- Haudenschild C.C. Pathobiology of restenosis after angioplasty / C.C. Haudenschild // Amer. J. of Medicine. 1993. — Vol. 94. — P. 40S-44S.
- Helft G. Acute antithrombotic effect of a front-loaded regien of clopidogrel in patients with atherosclerosis on aspirin / G. Helft et al. // Arteriosclerosis, Thrombosis a. Vascular Biology. 2000. — Vol. 20. — P. 2316−2321.
- Herbert J.M. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit / J.M. Herbert et al. // Thrombosis a. Haemostasis. 1998. — Vol. 80. — 512−518.
- Hirsh J. Heparin // New England J. of Medicine. 1991. — Vol. 324. -P. 1565−1574.
- Hirsh J. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety / J. Hirsh // Chest. 1998. — Vol. 114. — P. 489S-510S.
- Histologic studies in PTC A for chronic total occlusion: comparison of tapering and abrupt of occlusion and short and long occluded segments // J. of Amer. College of Cardiology. 1993. — Vol. 21. — P. 604−611.
- Holt G.W. The result of percutaneous transluminal coronary angioplasty (PTCA) in post infarction angina pectoris / G.W. Holt et al. // J. of Amer. College of Cardiology. 1986. — Vol. 7. — P. 62.
- Hopkins J. Recurrent ischemia in the zone of prior myocardial infarction: Result of coronary angioplasty of the infact-relaterd artery / J. Hopkins et al. // Amer. Heart J. 1988. — Vol. 115. — P. 14.
- Hoshio A. Significance of coronary artery tone in patients with wasospastic angina / A. Hoshio, H. Korate, H. Mashiba // J. of Amer. College of Cardiology. 1989. -Vol. 589.-P. 14.
- Inhibition of the platelet glycoprotein Ilb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction / PRISMPLUS study investigators // New England J. of Medicine. 1998. — Vol. 338. — P. 1488−1497.
- Invasive compared with non-invasive treatment in unstable coronary-artery disease / FRISC II prospective randomised multicentre study // Lancet. 1999. — Vol. 354. — P. 708−715.
- Jordan C. Reduction of acute thrombosis rate after coronary stenting using a new anticoagulation protocol / C. Jordan et al. // Circulation. -1994.-Vol. 90.-P. 1−125.
- Judkins M.P. Selective coronary arteriography: a percutaneous transfemoral technic / M.P. Judkins M. P // Radiology. 1967. — Vol.89. — P. 815.
- Karsch K.R. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of REDUCE-trial / K.R. Karsch et al. // J. of Amer. College of Cardiology. 1996. — Vol. 28. -P. 1437−1443.
- Kereiakes D.J. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention / D.J. Kereiakes et al. // J. of Invasive Cardiology. 2001. — Vol. 13. — P. 272 278.
- Kereiakes D.J. Enoxaparin-abciximab combination for percutaneous coronary intervention: final result of the NICE 1 and 4 trials / D.J. Kereiakes et al. // J. of Amer. College of Cardiology. 2000. — Vol. 35. — P. 92 A.
- Kereiakes D.J. Enoxaparin-abciximab combination for percutaneous coronary intervention: final result of the NICE 4 trial / D.J. et al. // Amer. J. of Cardiology.-2000.-Vol. 86.-P. 141.
- Kong Df. Clinical outcomes of therapeutic agents that block the platelet glycoprotein Ilb/IIIa integrin in ischemic heart disease / Df. Kong // Circulation. — 1998. — Vol. 98. — P. 2829−2835.
- Kupfer Y. Ticlopidine and thrombotic thrombocytopenic purpura / Y. Kupfer, S. Tessler // New England J. of Medicine. 1997. — Vol. 337. — P. 1245.
- Lefkovits J. Platelet glycoprotein Ilb/IIIa receptors in cardiovascular medicine / J. Lefkovits, E.F. Plow, E.J. Topol // New England J. of Medicine. 1995. — Vol. 332. — P. 1553−1559.
- Leon M.B. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting / M.B. Leon et al. // New England J. of Medicine. 1998. — Vol. 339. — P. 1665−1671.
- Lewis H.D. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina / H.D.Lewis et al. // New England J. of Medicine. 1983.- Vol. 309. — P. 396−403.
- Lincoff A.M. Complimentary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein Ilb/IIIa receptors / A.M. Lincoff et al. // New England J. of Medicine. — 1999. — Vol. 341. — P. 319−327.
- Lincoff A.M. Multicenter randomized double blind pilot study with heparin treatment according patient body weight / A.M. Lincoff et al. // J. of Amer. College of Cardiology. 1995. — Vol. 80A, sp. is. — P. 711−713.
- Love B.B. Adverse haematological effects of ticlopidine: prevention, recognition and management / B.B. Love, J. Biller, M. Gent // Drug Safety. 1998.-Vol. 19.-P. 89−98.
- Madan M. Coronary stenting in unstable angina: early and late clinical outcomes / M. Madan et al. // Canad. J. of Cardiology. 1998. — Vol. 14. -P. 1109−1114.
- Malosky S. Comparison of result of intracoronary stenting in patients with unstable vs stable angina / S. Malosky, J. Hirschfeld, H. Herrmann // Catheter a. Cardiovascular Diagnosis. 1994. — Vol. 31. — P. 95−101.
- Mann J. Plaque constituents in patients with stable and unstable angina an atherectomy study / J. Mann et al. // J. of Amer. College of Cardiology. 1995. — Vol. 80A, sp. is. — P. 34A.
- McGarry T.F. (Jr.) The relationship of anticoagulation level and complications after successful PTCA / T.F. McGarry (Jr.) et al. //Amer. Heart J. 1992. — Vol. 123. — P. 1445.
- McMahon M.M. Quantitative coronary angiography: measurements of the «critical» stenosis in patients with unstable angina and single-vessels disease without collaterals / M.M. McMahon et al. // Circulation 1979- 60:106−113.
- Mehta S.R. Effect of pretreatment with Clopidogrel and aspirin followed by long-term therapy in patient undergoing percutaneous coronary intervention / S.R. Mehta // Lancet. 2001. — Vol. 358. — P. 527−533.
- Miltenburg A.J.M. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris / A.J.M. Miltenburg et al. // J. of Amer. College of Cardiology. 1995. — Vol. 25. — P. 1286.
- Moliterno D.J. Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study / D.J. Moliterno et al. // Lancet. 2002. — Vol. 360. — P. 355−360.
- Morrison D.A. Percutaneous transluminal coronary angioplasty for rest angina pectoris requiring intravenosus nitroglycerin and intraaortic balloon counterpulsation / D.A. Morrison D.A. // Amer. J. of Cardiology. -1990.-Vol. 66.-P. 168.
- Morrison D.A. Coronary angioplasty for medical refractory unstable angina within 30 days of acute myocardial infarction / D.A. Morrison // Amer. Heart J. 1990. -Vol. 120. — P. 256 .
- Mulcahy R. Natural history and prognosis of unstable angina / R. Mulcahy // Amer. Heart J. 1985. Vol. 109. — P. 753−759.
- Mulcahy R. Unstable angina: Natural history and determinants of prognosis / R. Mulcahy et al. // Amer. J. of Cardiology. 1981. — Vol. 48. -P. 525.
- Muller C. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents / C. Muller et al. // Circulation 2000. Vol. 101. -P. 590−593.
- Muller J.E. Nifedipin and conventional therapy for unstable angina pectoris: A randomized, double-blind comparison / J.E. Muller et al. // Circulation. 1984. — Vol. 69. — P. 728−739.
- Myler R.X. Unstable angina and coronary angioplasty / R.X. Myler et al.//Circulation.- 1990.-Vol. 82, pt2-P. 88−95.
- New perspective on aspirin therapy: proceedings of a symposium / Aspirin foundation of America, Tulane Univ. Medic. Center // Amer. J. of Medicine. 1983, Vol. 74, ptB.-P. 1−109.
- Noble S. Enoxaparin. A review or its clinical potential in the management of coronary artery disease / S. Noble, C.M. Spencer // Drugs. -1998. Vol. 56, № 2. — P. 259−272.
- O’Shea J.C. Platelet glycoprotein Ilb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial / J.C. CTShea et al. // JAMA. 2001. — Vol. 285. — P. 24 682 473.
- Ogiblby J.D. Adequate heparinization during PTCA: Assessment using activated clotting time / J.D. Ogiblby et al. // Catheter a. Cardiovascular Diagnosis. 1989. — Vol. 18. — P. 206.
- Oler A. Adding heparin to aspirin reduce the incidence of myocardial infarction and death in patients with unstable angina meta-analysis / A. Oler et al. // JAMA. 1996. — Vol. 276. — P. 811−815.
- Page Y. Thrombotic thrombocytopenic purpura related to ticlopidine / Y. Page // Lancet. 1991. — Vol. 337. — P. 774−776.
- Perry R.A. Coronary angioplasty in unstable angina and stable angina: A comparison of success and complications / R.A. Perry et al. // Brit. Heart J.- 1988.-Vol. 60.-P. 367.
- Peterson E.D. Influence of physician specialty on care and outcomes of acute coronary syndrome patients: result from CRUSADE / E.D. Peterson et al. // J. of Amer. College Cardiology. 2003. — Vol. 41, suppl. B. — P. 534−535.
- Peterson E.D. Risk stratification after myocardial infarction / E.D. Peterson, L.J. Shaw, R.M. Califf// Annals of Internal Medicine. 1997. -Vol. 126.-P. 561−582.
- Physicians' desk reference. 56th ed. — Montlvale: Med. Econ. Co, 2002.-3085 p.
- Platelet glycoprotein Ilb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization // New England J. of Medicine. 1997.-Vol. 336.-P. 1689−1696.
- Plokker H.W.T. Percutaneous transluminal coronary angioplasty in patients with unstable angina pectoris refractory to the medical therapy / H.W.T. Plokker et al. // Catheter a. Cardiovascular Diagnosis. 1988. -Vol. 14.-P. 15.
- Puri R.N. Clopidogrel, a ticlopidine analog, impairs the interaction of ADP with receptor mediating adenyl cyclase without altering the modification of aggregin / R.N. Puri // Clinic. Research. 1991. — Vol. 39. -P. 366A.
- Quigley P.J. Percutaneous transluminal coronary angioplasty in unstable angina: Comparison with stable angina / P.J. Quigley et al. // Brit. Heart J. 1986. Vol. 55. — P. 227.
- Rabah A. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three regimes after successful coronary inventory / A. Rabah et al. // J. of Amer. College of Cardiology. 1999. — Vol. 34. — P. 461 -467. '
- Rafflenbeul W. Quantitative coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy / W. Rafflenbeul et al. // Amer. J. of Cardiology. 1979. — Vol. 43. — P. 699−707.
- Rahimtoola S. H: Coronary bypass surgery for unstable angina/ S.H. Rahimtoola // Circulation. 1984. — Vol. 69. — P 842.
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention / The IMPACT II investigators // Lancet. 1997. — Vol. 349. — P. 1422−1428.
- Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory angina / The CAPTURE Investigators // Lancet. 1997.-Vol. 349.-P. 1429−1435.
- Rebuzzi A.G. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris / A.G. Rebuzzi et al. // Amer. J. of Cardiology. 1998. -Vol. 82.-P. 715−719.
- Ridker P.M. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men / P.M. Ridker // New England J. of Medicine. 1997. — Vol. 336. — P. 973−979.
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease / RISC Group // Lancet. 1990. — Vol. 336. — P. 827−830.
- Robinson N.M. Is unstable angina a contraindication to intracoronary stent insertion? / N.M. Robinson et al. // J. of Invasive Cardiology. 1996. -Vol. 8.-P. 351−356.
- Robinson N.M. Is Unstable angina a contraindication to intracoronary stent insertion? // J. of Invasive Cardiology. 1996. -Vol. 8. — P. 351−356.
- Roubin G.S. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty / G.S. Roubin et al. // Circulation. 1992. — Vol. 85. — P. 916−927.
- Rupprecht H.J. Short and long-term outcomes of PTCA in patient with stable angina and unstable angina / H.J. Rupprecht et al. // Europ. Heart J. 1990. — Vol. 11. — P. 964.
- Ryan T.J. Guidelines for percutaneous transluminal coronary angioplasty / T.J. Ryan et al. // J. of Amer. College of Cardiology. 1993. — Vol. 22. — P. 2033−2054.
- Safian R.D. Coronary Intervention: preparation, equipment and technique / R.D. Safian, M.S. Freed // The manual of interventional cardiology. Royal Oak, 2002. — P. 1−32.
- Safian R.D. Usefulness of PTCA for unstable angina pectoris after non-Q wave acute myocardial infarction / R.D. Safian et al. // Amer. J. of Cardiology.-1987.-Vol. 59.-P. 263
- Savas V. Angioplasty outcome using long balloons in high-risk lesions / V. Savas et al. // J. of Amer. College of Cardiology. 1992. -Vol. 19. — P. 34A.
- Scanlon P. J: The intermediate coronary syndrome / P.J. Scanlon // Progress in Cardiovascular Diseases. 1982. — Vol. 23. — P. 351−364.
- Schomig A. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents / Schomig A. et al. // New England J. of Medicine. 1996. — Vol. 334. — P. 1084−1089.
- Scott J.A. Use of the activated coagulation time as a measure of anticoagulation during interventional procedures / J.A. Scott, A. Berenstein, D. Blumenthal // Radiology. 1986. — Vol. 158. — P. 849.
- Scull L. Early invasive versus conservative strategy in non-ST elevation myocardial infarction / L. Scull et al. // J. of Amer. College of Cardiology. 2000. — Vol. 35. — P. 895−902.
- Serruys P.W. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease / P.W. Serruys et al. // New England J. of Medicine. 1994. — Vol. 331. — P.489−495.
- Serruys P.W. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II) / P.W. Serruys et al. // Lancet. 1998. -Vol. 352.-P. 673−681.
- Shani J. Clinical cardiology: PTCA in ischemic syndromes / J. Shani // Circulation. 1992. — Vol. 86. — P. 852.
- Sharma B. Percutaneous transluminal coronary angioplasty of one vessel for refractory unstable angina pectoris: efficacy in single and multivessels disease / B. Sharma et al. // Brit. Heart J. 1988. — Vol. 59. -P. 280.
- Sharma S.K. Clinical, angiographic, and procedural determinants of major and minor coronay dissection during angioplasty / S.K.Sharma et al. // Amer. Heart J. 1993. — Vol. 126. — P. 39−47.
- Shimada K. Efficacy and safety of early coronary stenting for unstable angina / K. Shimada et al. // Catheter a. Cardiovascular Diagnosis. 1998. -Vol. 43.-P. 381−385.
- Smith S.C. ACC/AHA guidelines for percutaneous transluminal coronary angioplasty, (revision of the 1993 PTCA Guidelines)/ S.C. Smith etal. // J. of Amer. College of Cardiology. 2001. — Vol. 37. — P. 2239.
- Song K.H. Interaction of ACE inhibitors and aspirin in patients with congestive heart failure / K.H. Song, R. Fedyk, R. Hoover // Annals of Pharmacotherapy. 1999. — Vol. 33. — P. 375−377.
- Spacek R. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial / R. Spacek et al. // Europ. Heart J. 2002. — Vol. 23. — P. 230−238.
- Stammen F. Immediate and follow-up result of the conservative coronary angioplasty strategy of unstable pectoris / F. Stammen et al. // Amer. J. of Cardiology. 1992. — Vol. 69. — P. 1533.
- Steffenino G. Follow-up result of treatment of unstable angina by coronary angioplasty / G. Steffenino // Brit. Heart J. 1987. — Vol. 57. — P. 416.
- Steinhubl S.R. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial / S.R. Steinhubl et al. // JAMA. 2002. — Vol. 228.-P.2411−2420.
- Stone P.H. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction / P.H. Stone et al. // Europ. Heart J. 1999. — Vol. 20. — P. 1084−1093.
- Sugrue D.R. Coronary artery thrombus as risk factor for acute vessel occlusion during PTCA: Improved results / D.R. Sugrue, D.R. Holmes, H.C. Smith // Brit. Heart J. 1986. — Vol. 53. — P. 62−66.
- Suryapranata H. Percutaneous transluminal coronary angioplasty for angina pectoris after a non-Q wave acute myocardial infarction / H. Suryapranata et al. // Amer. J. of Cardiology. 1988. — Vol. 61. — P. 240.
- Swanson K.T. Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty / K.T. Swanson et al. // Amer. J. of Cardiology. 1984. — Vol. 545. — P. 447−448.
- Szto G.Y.T. Safety of 10 days of ticlopidine after coronary stenting: a randomized comparison with 30 days / G.Y.T. Szto et al. // J. of Amer. College Cardiology. 1998. — Vol. 31. — P. 352A.
- Tan K. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience / K. Tan et al. // J. of Amer. College of Cardiology. 1995. — Vol. 25. — P. 855−65.
- Tcheng J.E. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial / J.E. Tcheng et al. // Lancet. 2000. — Vol. 356. — P. 2037−2044.
- Techniques in coronary artery stenting / Ed.: F. Colombo, J. Tobis. -London: Martin Dunitz, 2000. 432 p.
- Theroux P. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction / P. Theroux, V. Fuster // Circulation. — 1998. -Vol. 97.-P. 1195−1206.
- Theroux P. Aspirin, heparin, or both to treat acute unstable angina / P. Theroux et al. // New England J. of Medicine. 1988. — Vol. 319. — P. 1105−1111.
- Theroux P. Improved cardiac outcomes in diabetic unstable angina/non-Q wave myocardial infarction patients treated with tirofiban and heparin / P. Theroux et al. // Circulation. 1998. — Vol. 98, suppl. 1. — P. 1359.
- Theroux P. Reactivation of unstable angina after the discontinuation of heparin / P. Theroux et al. // New England J. of Medicine. 1992. -Vol. 327.-P. 141−145.
- Timmis A.D. Early percutaneous transluminal coronary angioplasty in the management of unstable angina / A.D. Timmis et al. // Intern. J. of Cardiology.- 1987.-Vol. 14.-P. 25.
- Topol E. Textbook of interventional cardiology / E. Topol. 3rd ed. -Philadelphia: WB Saunders Co, 1988. -2504 c.
- Topol E.J. Randomised trial of coronary intervention with antibody against platelet Ilb/IIIa integrin for reduction of clinical restenosis result at six months / E.J. Topol et al. // Lancet. 1994. Vol. 343. — P. 881−886.
- Topol E.J. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty / E.J. Topol et al. // Circulation. 1993. -Vol. 87.-P. 1622−1629.
- Unstable angina / Ed. W. Bleifeld W. et al. New York: Spinger-Verlag, 1990. — 270 p.
- Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty / The EPIC Investigators // New England J. of Medicine. 1994. — Vol. 330. — P. 956 961.
- Wallentin L. Low-molecular-weight heparin during instability in coronary artery disease / L. Wallentin et al. // Lancet. 1996. — Vol. 347. -P. 561−568.
- Warkentin Т.Е. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin / Т.Е. Warkentin et al. // New England J. of Medicine. 1995. — Vol. 332. — P. 1330−1335.
- Wiliams D. PTCA for acute myocardial ischemia: the TIMI-3 experience / D. Wiliams et al. // Circulation. 1994. — Vol. 90. — P. 1−433.
- Xiao Z. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. / Z. Xiao, P. Theroux // Circulation. 1998. -Vol. 97.-P. 251−256.
- Yusuf S. Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation / S. Yusuf et al. // New England J. of Medicine. 2001. — Vol. 345. -P. 494−502.
- Yusuf S. Variation between countries in invasive cardiac procedures and outcome in patients with suspected unstable angina or myocardial infarction without initial St elevation / S. Yusuf et al. // Lancet. 1998. -Vol. 352.-P. 507−514.
- Zidar J.P. Improved acute results for PTCA of long coronary lesions using long angioplasty balloon catheters / J.P. Zidar et al. // J. of Amer. College of Cardiology. 1992. — Vol. 19. — P. 34A.